contact
Read full press release »
Learn more about
K
RYSTEXXA »
See Full Prescribing Information
»
MORE
CONTACT US
|
PRIVACY
|
TERMS OF USE
Copyright © 2013 Savient Pharmaceuticals, Inc. All rights reserved.
Leadership
Board of Directors
Corporate Governance
Overview
K
RYSTEXXA
®
(pegloticase)
Oxandrin
®
(oxandrolone)
Overview
Stock Information
SEC Filings
Press Releases
Events & Webcasts
Corporate Governance
Investor FAQs
Investor Contacts
Email Alerts
Mission Statement
Investigator Sponsored Trials
Medical Education
The Savient Experience
Current Opportunities
